Digital rheumatology in the era of COVID-19: results of a national patient and physician survey.

Anna KernderHarriet MorfPhilipp KlemmDiana VossenIsabell HaaseJohanna MuckeMarco MeyerArnd KleyerPhilipp SewerinGerlinde BendzuckSabine EisJohannes Knitza Krusche Martin

Published in: RMD open (2021)

The COVID-19 pandemic instigated an increase in patients' and rheumatologists' acceptance and usage of DHAs, possibly introducing a permanent paradigm shift in the management of RMDs.

Keyphrases

end stage renal disease
coronavirus disease
ejection fraction
sars cov
newly diagnosed
chronic kidney disease
emergency department
prognostic factors
cross sectional
patient reported outcomes
juvenile idiopathic arthritis